
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $65.2M | $117M | $99.6M | $118.4M | $114.4M | |
Revenue Growth (YoY) | 68.73% | 79.4% | -14.88% | 18.9% | -3.41% | |
Cost of Revenues | $49M | $93M | $66.8M | $86.4M | $85.2M | |
Gross Profit | $16.2M | $24M | $32.8M | $32M | $29.2M | |
Gross Profit Margin | 24.9% | 20.54% | 32.96% | 27.06% | 25.49% | |
R&D Expenses | $9.7M | $8.1M | $5.1M | $4.7M | $4.5M | |
Selling, General & Admin | $30.3M | $47.8M | $24.2M | $30.1M | $29.1M | |
Other Inc / (Exp) | -$7.5M | -$1.8M | -$1.8M | -$4.3M | -$11.4M | |
Operating Expenses | $45.6M | $61.9M | $33.7M | $36.6M | $35.6M | |
Operating Income | -$29.4M | -$37.9M | -$828K | -$4.6M | -$6.4M | |
Net Interest Expenses | $5.3M | $4.1M | $7.3M | $4.4M | $2.7M | |
EBT. Incl. Unusual Items | -$42.2M | -$43.7M | -$10M | -$13.2M | -$20.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$345K | $183K | $65K | $118K | -$185K | |
Net Income to Company | -$41.8M | -$43.9M | -$10M | -$13.3M | -$20.4M | |
Minority Interest in Earnings | -- | -- | -- | $1.3M | $1.7M | |
Net Income to Common Excl Extra Items | -$41.8M | -$43.9M | -$10M | -$12M | -$18.7M | |
Basic EPS (Cont. Ops) | -$0.61 | -$0.56 | -$0.12 | -$0.17 | -$0.21 | |
Diluted EPS (Cont. Ops) | -$0.61 | -$0.56 | -$0.12 | -$0.17 | -$0.21 | |
Weighted Average Basic Share | $69M | $79.1M | $84.8M | $87.6M | $95M | |
Weighted Average Diluted Share | $69M | $79.1M | $84.8M | $87.6M | $95M | |
EBITDA | -$28.1M | -$30M | $5.4M | -$3.7M | -$12.5M | |
EBIT | -$36.9M | -$39.6M | -$2.6M | -$8.8M | -$17.8M | |
Revenue (Reported) | $65.2M | $117M | $99.6M | $118.4M | $114.4M | |
Operating Income (Reported) | -$29.4M | -$37.9M | -$828K | -$4.6M | -$6.4M | |
Operating Income (Adjusted) | -$36.9M | -$39.6M | -$2.6M | -$8.8M | -$17.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $21M | $23.4M | $25.5M | $30.9M | $19.3M | |
Revenue Growth (YoY) | 112.99% | 11.37% | 9.03% | 20.95% | -37.58% | |
Cost of Revenues | $16.5M | $18.3M | $18.3M | $23.4M | $13.3M | |
Gross Profit | $4.6M | $5.1M | $7.3M | $7.5M | $5.9M | |
Gross Profit Margin | 21.76% | 21.79% | 28.39% | 24.35% | 30.82% | |
R&D Expenses | $2.8M | $2.1M | $1.2M | $1.3M | $1.1M | |
Selling, General & Admin | $9.1M | $9.8M | $6.6M | $6.8M | $7.4M | |
Other Inc / (Exp) | -$5.7M | $585K | -$3M | -$520K | -$7.5M | |
Operating Expenses | $13.4M | $13.4M | $8.1M | $8.7M | $9M | |
Operating Income | -$8.8M | -$8.3M | -$860K | -$1.2M | -$3.1M | |
Net Interest Expenses | $1.2M | $943K | $1.5M | $889K | $501K | |
EBT. Incl. Unusual Items | -$15.7M | -$8.6M | -$5.4M | -$2.6M | -$11.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$349K | $215K | $50K | $75K | -$240K | |
Net Income to Company | -$15.4M | -$8.8M | -$5.4M | -$2.6M | -$10.9M | |
Minority Interest in Earnings | -- | -- | -- | $348K | $410K | |
Net Income to Common Excl Extra Items | -$15.4M | -$8.8M | -$5.4M | -$2.3M | -$10.4M | |
Basic EPS (Cont. Ops) | -$0.20 | -$0.11 | -$0.06 | -$0.03 | -$0.08 | |
Diluted EPS (Cont. Ops) | -$0.20 | -$0.11 | -$0.06 | -$0.03 | -$0.08 | |
Weighted Average Basic Share | $75.5M | $83.3M | $87.1M | $88M | $95.6M | |
Weighted Average Diluted Share | $75.5M | $83.3M | $87.1M | $88M | $95.6M | |
EBITDA | -$12.1M | -$5.3M | -$2.9M | -$242K | -$9.2M | |
EBIT | -$14.5M | -$7.7M | -$3.8M | -$1.7M | -$10.6M | |
Revenue (Reported) | $21M | $23.4M | $25.5M | $30.9M | $19.3M | |
Operating Income (Reported) | -$8.8M | -$8.3M | -$860K | -$1.2M | -$3.1M | |
Operating Income (Adjusted) | -$14.5M | -$7.7M | -$3.8M | -$1.7M | -$10.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $65.2M | $117M | $99.6M | $118.4M | $114.4M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $49M | $93M | $66.8M | $86.8M | $85.2M | |
Gross Profit | $16.2M | $24M | $32.8M | $31.7M | $29.2M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $9.7M | $8.1M | $5.1M | $4.7M | $4.5M | |
Selling, General & Admin | $30.3M | $47.8M | $24.2M | $29.8M | $29.1M | |
Other Inc / (Exp) | -$7.5M | -$1.8M | -$1.8M | -$4.3M | -$11.4M | |
Operating Expenses | $45.6M | $61.9M | $33.7M | $36.3M | $35.6M | |
Operating Income | -$29.4M | -$37.9M | -$828K | -$4.6M | -$6.4M | |
Net Interest Expenses | $5.3M | $4.1M | $7.3M | $4.4M | $2.7M | |
EBT. Incl. Unusual Items | -$42.2M | -$43.7M | -$9.9M | -$13.2M | -$20.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$345K | $181K | $87K | $118K | -$185K | |
Net Income to Company | -$41.8M | -$43.9M | -$10M | -$13.3M | -$20.4M | |
Minority Interest in Earnings | -- | -- | -- | $1.3M | $1.7M | |
Net Income to Common Excl Extra Items | -$41.8M | -$43.9M | -$10M | -$12M | -$18.7M | |
Basic EPS (Cont. Ops) | -$0.60 | -$0.55 | -$0.11 | -$0.16 | -$0.18 | |
Diluted EPS (Cont. Ops) | -$0.60 | -$0.55 | -$0.11 | -$0.16 | -$0.18 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$28.1M | -$30M | $5.4M | -$3.7M | -$12.5M | |
EBIT | -$36.9M | -$39.6M | -$2.6M | -$8.8M | -$17.8M | |
Revenue (Reported) | $65.2M | $117M | $99.6M | $118.4M | $114.4M | |
Operating Income (Reported) | -$29.4M | -$37.9M | -$828K | -$4.6M | -$6.4M | |
Operating Income (Adjusted) | -$36.9M | -$39.6M | -$2.6M | -$8.8M | -$17.8M |
Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
---|---|---|---|---|---|---|
Revenue | $117M | $99.6M | $118.4M | $114.4M | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $93M | $66.8M | $86.8M | $85.2M | -- | |
Gross Profit | $24M | $32.8M | $31.7M | $29.2M | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $8.1M | $5.1M | $4.7M | $4.5M | -- | |
Selling, General & Admin | $47.8M | $24.2M | $29.8M | $29.1M | -- | |
Other Inc / (Exp) | -$1.8M | -$1.8M | -$4.3M | -$11.4M | -- | |
Operating Expenses | $61.9M | $33.7M | $36.3M | $35.6M | -- | |
Operating Income | -$37.9M | -$828K | -$4.6M | -$6.4M | -- | |
Net Interest Expenses | $4.1M | $7.3M | $4.4M | $2.7M | -- | |
EBT. Incl. Unusual Items | -$43.7M | -$9.9M | -$13.2M | -$20.6M | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $181K | $87K | $118K | -$185K | -- | |
Net Income to Company | -$43.9M | -$10M | -$13.3M | -$20.4M | -- | |
Minority Interest in Earnings | -- | -- | $1.3M | $1.7M | -- | |
Net Income to Common Excl Extra Items | -$43.9M | -$10M | -$12M | -$18.7M | -- | |
Basic EPS (Cont. Ops) | -$0.55 | -$0.11 | -$0.16 | -$0.18 | -- | |
Diluted EPS (Cont. Ops) | -$0.55 | -$0.11 | -$0.16 | -$0.18 | -- | |
Weighted Average Basic Share | $316.8M | $339.4M | $350M | $380.2M | -- | |
Weighted Average Diluted Share | $316.8M | $339.5M | $350M | $380.2M | -- | |
EBITDA | -$30M | $5.4M | -$3.7M | -$12.5M | -- | |
EBIT | -$39.6M | -$2.6M | -$8.8M | -$17.8M | -- | |
Revenue (Reported) | $117M | $99.6M | $118.4M | $114.4M | -- | |
Operating Income (Reported) | -$37.9M | -$828K | -$4.6M | -$6.4M | -- | |
Operating Income (Adjusted) | -$39.6M | -$2.6M | -$8.8M | -$17.8M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $18.6M | $12.9M | $8.4M | $7M | $4.1M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $10.6M | $13.7M | $13.7M | $13.2M | $8.3M | |
Inventory | $2.6M | $2.6M | $2.6M | $1.8M | $1.6M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $3.4M | $1.9M | $2.8M | $2.2M | $1.2M | |
Total Current Assets | $35.3M | $31.3M | $27.7M | $24.3M | $15.2M | |
Property Plant And Equipment | $4.4M | $4.7M | $3.3M | $3.6M | $893K | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $22.6M | $23.4M | $23.4M | $23.4M | $21.7M | |
Other Intangibles | $22.5M | $16.7M | $11M | $12.4M | $2.6M | |
Other Long-Term Assets | $1M | $728K | $423K | $88K | $97K | |
Total Assets | $85.8M | $76.8M | $65.9M | $63.9M | $40.5M | |
Accounts Payable | $18.5M | $29.6M | $11M | $15.2M | $15.3M | |
Accrued Expenses | $26.1M | $29M | $24.4M | $22.6M | $15.4M | |
Current Portion Of Long-Term Debt | $4.7M | $12K | $4.7M | $7.7M | $3.6M | |
Current Portion Of Capital Lease Obligations | $319K | $273K | $273K | $91K | -- | |
Other Current Liabilities | -- | -- | $3.1M | $607K | -- | |
Total Current Liabilities | $51M | $60.1M | $44.5M | $46.8M | $36.4M | |
Long-Term Debt | $19.4M | $26.6M | $7.1M | $771K | $150K | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $77.6M | $87.7M | $66.9M | $62.3M | $48.9M | |
Common Stock | $77K | $83K | $16.3M | $18.9M | $14.1M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $8.1M | -$10.9M | -$17.2M | -$27.6M | -$31.8M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | $10.3M | $9.4M | |
Total Equity | $8.1M | -$10.9M | -$1M | $1.6M | -$8.4M | |
Total Liabilities and Equity | $85.8M | $76.8M | $65.9M | $63.9M | $40.5M | |
Cash and Short Terms | $18.6M | $12.9M | $8.4M | $7M | $4.1M | |
Total Debt | $24.1M | $26.7M | $11.9M | $8.5M | $3.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $18.6M | $12.9M | $8.4M | $7M | $4.1M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $10.6M | $13.7M | $13.7M | $13.2M | $8.3M | |
Inventory | $2.6M | $2.6M | $2.6M | $1.8M | $1.6M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $3.4M | $1.9M | $2.8M | $2.2M | $1.2M | |
Total Current Assets | $35.3M | $31.3M | $27.7M | $24.3M | $15.2M | |
Property Plant And Equipment | $4.4M | $4.7M | $3.3M | $3.6M | $893K | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $22.6M | $23.4M | $23.4M | $23.4M | $21.7M | |
Other Intangibles | $22.5M | $16.7M | $11M | $12.4M | $2.6M | |
Other Long-Term Assets | $1M | $728K | $423K | $88K | $97K | |
Total Assets | $85.8M | $76.8M | $65.9M | $63.9M | $40.5M | |
Accounts Payable | $18.5M | $29.6M | $11M | $15.2M | $15.3M | |
Accrued Expenses | $26.1M | $29M | $24.4M | $22.6M | $15.4M | |
Current Portion Of Long-Term Debt | $4.7M | $12K | $4.7M | $7.7M | $3.6M | |
Current Portion Of Capital Lease Obligations | $319K | $273K | $273K | $91K | -- | |
Other Current Liabilities | -- | -- | $3.1M | $607K | -- | |
Total Current Liabilities | $51M | $60.1M | $44.5M | $46.8M | $36.4M | |
Long-Term Debt | $19.4M | $26.6M | $7.1M | $771K | $150K | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $77.6M | $87.7M | $66.9M | $62.3M | $48.9M | |
Common Stock | $77K | $83K | $16.3M | $18.9M | $14.1M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | $10.3M | $9.4M | |
Total Equity | $8.1M | -$10.9M | -$1M | $1.6M | -$8.4M | |
Total Liabilities and Equity | $85.8M | $76.8M | $65.9M | $63.9M | $40.5M | |
Cash and Short Terms | $18.6M | $12.9M | $8.4M | $7M | $4.1M | |
Total Debt | $24.1M | $26.7M | $11.9M | $8.5M | $3.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$41.8M | -$43.9M | -$10M | -$13.3M | -$20.4M | |
Depreciation & Amoritzation | $8.8M | $9.6M | $8M | $5.1M | $5.3M | |
Stock-Based Compensation | $11.3M | $12.7M | $3M | $6.3M | $6.2M | |
Change in Accounts Receivable | $3.4M | -$3.1M | $29K | -$32K | $4.9M | |
Change in Inventories | $32K | -$31K | $3K | $795K | $215K | |
Cash From Operations | -$9.5M | -$9.1M | -$3.8M | $6.8M | $6.4M | |
Capital Expenditures | $3.2M | $3.8M | $2.5M | $4M | $3.1M | |
Cash Acquisitions | $2.4M | -$150K | -- | -- | -- | |
Cash From Investing | -$791K | -$4M | -$2.5M | -$4M | -$3.1M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -$509K | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $17.7M | $7M | $4.7M | $1.7M | -- | |
Long-Term Debt Repaid | -$11M | -$351K | -$300K | -$3.4M | -$4.7M | |
Repurchase of Common Stock | -- | -- | -$2.2M | -$2.6M | -$999K | |
Other Financing Activities | -$190K | -- | -$426K | -- | -- | |
Cash From Financing | $16.6M | $7.5M | $1.8M | -$4.3M | -$6.2M | |
Beginning Cash (CF) | $12.4M | $18.8M | $13.2M | $8.6M | $7.1M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $6.3M | -$5.6M | -$4.5M | -$1.5M | -$3M | |
Ending Cash (CF) | $18.8M | $13.2M | $8.6M | $7.1M | $4.1M | |
Levered Free Cash Flow | -$12.7M | -$13M | -$6.3M | $2.8M | $3.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$15.4M | -$8.8M | -$5.4M | -$2.6M | -$10.9M | |
Depreciation & Amoritzation | $2.4M | $2.4M | $944K | $1.4M | $1.4M | |
Stock-Based Compensation | $3.2M | $644K | $504K | $917K | $1.7M | |
Change in Accounts Receivable | $5.6M | $4.2M | $227K | $2.9M | $523K | |
Change in Inventories | $27K | $297K | $1K | $291K | $48K | |
Cash From Operations | -$408K | $1.1M | $784K | $3M | -$4.3M | |
Capital Expenditures | $980K | $857K | $401K | $1.3M | $995K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$980K | -$857K | -$401K | -$1.3M | -$995K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $2.5M | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$105K | $252K | $426K | -$170K | -$1.5M | |
Repurchase of Common Stock | -- | -- | -$224K | -$919K | -- | |
Other Financing Activities | -- | -- | -$426K | -- | -- | |
Cash From Financing | $2.6M | $252K | -$224K | -$1.1M | -$1.5M | |
Beginning Cash (CF) | $17.6M | $12.7M | $8.5M | $6.5M | $10.9M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $1.2M | $498K | $159K | $689K | -$6.7M | |
Ending Cash (CF) | $18.8M | $13.2M | $8.6M | $7.1M | $4.1M | |
Levered Free Cash Flow | -$1.4M | $246K | $383K | $1.8M | -$5.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$41.8M | -$43.9M | -$10M | -$13.3M | -$20.4M | |
Depreciation & Amoritzation | $8.8M | $9.6M | $8M | $5.1M | $5.3M | |
Stock-Based Compensation | $11.3M | $12.7M | $3M | $6.3M | $6.2M | |
Change in Accounts Receivable | $3.4M | -$3.1M | $29K | -$32K | $4.9M | |
Change in Inventories | $32K | -$31K | $3K | $795K | $215K | |
Cash From Operations | -$9.5M | -$9.1M | -$3.8M | $6.8M | $6.4M | |
Capital Expenditures | $3.2M | $3.8M | $2.5M | $4M | $3.1M | |
Cash Acquisitions | $2.4M | -$150K | -- | -- | -- | |
Cash From Investing | -$791K | -$4M | -$2.5M | -$4M | -$3.1M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -$509K | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $17.7M | $7M | -- | -- | -- | |
Long-Term Debt Repaid | -$11M | -$351K | -$300K | -$3.4M | -$4.7M | |
Repurchase of Common Stock | -- | -- | -$2.2M | -$2.6M | -$999K | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $16.6M | $7.5M | $1.8M | -$4.3M | -$6.2M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $6.3M | -$5.6M | -$4.5M | -$1.5M | -$3M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$12.7M | -$13M | -$6.3M | $2.8M | $3.2M |
Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$43.9M | -$10M | -$13.3M | -$20.4M | -- | |
Depreciation & Amoritzation | $9.6M | $8M | $5.1M | $5.3M | -- | |
Stock-Based Compensation | $12.7M | $3M | $6.3M | $6.2M | -- | |
Change in Accounts Receivable | -$3.1M | $29K | -$32K | $4.9M | -- | |
Change in Inventories | -$31K | $3K | $795K | $215K | -- | |
Cash From Operations | -$9.1M | -$3.8M | $6.8M | $6.4M | -- | |
Capital Expenditures | $3.8M | $2.5M | $4M | $3.1M | -- | |
Cash Acquisitions | -$150K | -- | -- | -- | -- | |
Cash From Investing | -$4M | -$2.5M | -$4M | -$3.1M | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -$509K | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $7M | $4.7M | $1.7M | -- | -- | |
Long-Term Debt Repaid | -$351K | -$300K | -$3.4M | -$4.7M | -- | |
Repurchase of Common Stock | -- | -$2.2M | -$2.6M | -$999K | -- | |
Other Financing Activities | -- | -$426K | -- | -- | -- | |
Cash From Financing | $7.5M | $1.8M | -$4.3M | -$6.2M | -- | |
Beginning Cash (CF) | $72.9M | $40.4M | $24.1M | $35.4M | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$5.6M | -$4.5M | -$1.5M | -$3M | -- | |
Ending Cash (CF) | $67.3M | $35.9M | $22.6M | $32.4M | -- | |
Levered Free Cash Flow | -$13M | -$6.3M | $2.8M | $3.2M | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.